Release Date: 04/04/14 09:42 Summary: Appendix 5B - Quarterly Cashflow Report Price Sensitive: Yes Download Document 117.94KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%